Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases

PURPOSE: Sarcopenia has been identified as a prognostic marker of clinical outcomes in several diseases. However, the influence of sarcopenia on non-surgical local treatments in breast cancer liver metastases (BCLM) is unknown. Therefore, the purpose of this study was to assess the effect of sarcope...

Descripción completa

Detalles Bibliográficos
Autores principales: Thormann, Maximilian, Heitmann, Franziska, March, Christine, Pech, Maciej, Hass, Peter, Surov, Alexey, Damm, Robert, Omari, Jazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528834/
https://www.ncbi.nlm.nih.gov/pubmed/36199942
http://dx.doi.org/10.5114/jcb.2022.119515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528834/
https://www.ncbi.nlm.nih.gov/pubmed/36199942
http://dx.doi.org/10.5114/jcb.2022.119515

Ejemplares similares